Filing Details
- Accession Number:
- 0001127602-15-021327
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-06-24 18:28:11
- Reporting Period:
- 2015-06-24
- Filing Date:
- 2015-06-24
- Accepted Time:
- 2015-06-24 18:28:11
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1236397 | Daniel Bradbury | 5200 Illumina Way San Diego CA 92122 | Yes | No | No | No |
Transaction Summary
Sold: | 1,700 shares | Avg. Price: $221.23 | Total Value: $376,097.80 |
Number of Shares After Transactions: | 14,376 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-06-24 | 1,700 | $75.66 | 16,076 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-06-24 | 1,100 | $220.61 | 14,976 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-06-24 | 200 | $221.31 | 14,776 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-06-24 | 400 | $222.90 | 14,376 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2015-06-24 | 1,700 | $0.00 | 1,700 | $75.66 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
4,000 | 2012-04-17 | 2021-05-10 | No | 4 | M | Direct |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sale price representing 1,100 shares sold ranging from $220.01 to $220.99 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 200 shares sold ranging from $221.01 to $221.61 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 400 shares sold ranging from $222.815 to $222.97 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.